Harte Hanks HHS Q2 2025 Earnings Narrow Loss Reported as Stock Inches Higher DLPN Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction RDVT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction OPHC Q1 2026 Earnings EPS Misses Estimates by 1475 HLI Q1 2026 Earnings EPS Misses Estimates Stock Declines 24 ALT Q1 2026 Earnings Narrowed Loss and EPS Beat Signal Progress in Metabolic Pipeline VRTS Q1 2026 Earnings EPS Misses Estimates on Negative Surprise NRXS Q1 2026 Earnings EPS Beats Estimates Despite Revenue Absence VTVT Q1 2026 Earnings Massive EPS Beat Driven by OneTime Items Stock Declines CPSS Q4 2025 Earnings Mixed Results as EPS Falls Short of Estimates Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported NVO Q1 2026 Earnings EPS Surges Past Estimates as Obesity Drug Sales Drive Margin Gains SNSE Q1 2026 Earnings EPS Significantly Below Estimates as Company Invests in Pipeline